RecruitingNot ApplicableNCT07340255

The 90% Effective Ventilation Pressure (EP90) for Esophageal Insufflation Avoidance During Anesthesia Induction

The 90% Effective Ventilation Pressure (EP90) for Esophageal Insufflation Avoidance During Anesthesia Induction: A Bias-Coin Design With Up-and-Down Sequential Allocation Trial


Sponsor

Affiliated Hospital of Jiaxing University

Enrollment

60 participants

Start Date

Sep 29, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Exploring the 90% Effective Ventilation Pressure (EP90) for Esophageal Insufflation Avoidance During Anesthesia Induction: The aim is to determine the optimal ventilation pressure for esophageal insufflation avoidance during anesthesia induction and to explore its guiding significance for anesthesia management. The goal is to provide a more precise and personalized ventilation pressure setting standard for clinical anesthesia, thereby enhancing the safety of the anesthesia induction phase.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria8

  • Age: 18-65 years, regardless of gender;
  • ASA classification: I-III;
  • Scheduled for elective general anesthesia surgery;
  • BMI: 18.0-28.0 kg/m²;
  • Preoperative fasting: Solid food \>6 hours, liquid \>2 hours;
  • Less than two from five criteria predicting difficult mask ventilation as described by Langeron et al.(Prediction of difficult mask ventilation. Anesthesiology 2000; 92:1229-36);
  • No severe underlying conditions such as heart, lung, liver, or kidney disease;
  • Signed informed consent and ability to cooperate with the study protocol.

Exclusion Criteria9

  • Pregnant or breastfeeding women;
  • History of upper gastrointestinal diseases such as gastroesophageal reflux disease, peptic ulcers, or hiatal hernia;
  • Recent (within 2 weeks) respiratory infections, chronic cough, similar symptoms, and other known or predictable respiratory system diseases;
  • Need for emergency surgery or airway obstruction after anesthesia induction requiring urgent intubation;
  • Inability to achieve adequate oxygenation during mask ventilation (e.g., SpO₂ \< 92% for 30 seconds, unresponsive to treatment);
  • History of contraindications or allergies to study medications;
  • Inability to understand the study content or refusal to cooperate;
  • Oropharyngeal or facial pathology;
  • with an indwelling gastric tube, and who had previously undergone gastric surgery.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERUltrasonic and inflation determination

Before induction, during ventilation, and after intubation, the anesthesiologist used a 7-14 MHz linear array probe for transverse (supraclavicular) positioning to monitor the left paratracheal esophageal region in real time. The main criterion for assessment was the absence of esophageal gas during ventilation, which was considered a positive response. If gas was detected entering the esophagus on ultrasound, it was recorded as a negative response. Additionally, the anesthesiologist performed a preoperative ultrasound examination of the gastric antrum to record baseline gastric antrum parameters. After successful tracheal intubation, a follow-up ultrasound of the gastric antrum was conducted to obtain postoperative gastric antrum parameters.


Locations(1)

Affiliated Hospital of Jiaxing University

Jiaxing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07340255


Related Trials